Amarin Corp Plc (AMRN)

[rosemountbomber]

Sleven, I was thinking about the "FDA did recently lower the bar for Alzheimer's disease approvals" and this came to mind.

Medicare is a few days ago announced that it will only cover Aduhelm in clinical trials. So it may not be so easy for Vascepa to get covered (other than the fact that it is a ton less expensive than Aduhelm) if Medicare using similar guideposts. And, of course, we know the insurance companies will resist as much as they can and do.

So an easy access to approval might not be as valuable as hoped. But better to have successful data and then worry about the rest.